Abstract:Background: PPAR- γ agonists (thiazolidinediones, TZDs) are used for the treatment of diabetes mellitus. Experimental and clinical data implicate that TZDs may mediate vascular effects in addition to the lowering of blood glucose. Aging is the predominant risk factor for the development of cardiovascular disease. Telomeres and telomere-associated proteins affect cellular aging, senescence and survival. We hypothesized that TZDs may regulate vascular telomere biology. Methods and Results: C57/Bl6 mice (Age 12 weeks, male) were subjected to treatment with pioglitazone (20mg/kg i.p. daily) or vehicle for 4 weeks. Telomere repeat amplification protocol (TRAP) assays showed a marked increase in aortic telomerase activity in the pioglitazone group to 319±30% vs. vehicle. Western blots demonstrated an increased protein levels of telomere-repeat binding factor 2 (367±20%) and reduced expression of the senescence- and apoptosis-related factors p16 (65±11%) and p53 (53±28%). Similar observations were made in mononuclear cells isolated from the spleen. Additionally, the number of spleen-derived endothelial progenitor cells was up-regulated in TZD-treated mice (550±36%). The physiologic significance of these findings was tested by induction of vascular oxidative stress in-vivo by injection of lipopolysaccharide (LPS, 125mg, i.p.). Endothelial apoptosis in the thoracic aorta was quantitated by hairpin oligonucleotid assays. LPS increased apotosis to 576±16 % of vehicle which was potently prevented in TZD-treated animals (Pio+LPS 241±12 %). All reported effects were significant with p<0.05, n = 6 –12 per group. Conclusions: TZD treatment up-regulates telomerase activity, telomere-capping proteins and induces anti-senescent effects in the vascular wall. The reduction of LPS-induced endothelial apoptosis indicates that the observed effects are physiologically relevant in mice. Our data improve the molecular understanding of the vascular effects of TZDs.

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

Rosiglitazone ameliorates the dysfunction of endothelial progenitor cells induced by advanced glycation end products

Pioglitazone Attenuates Aging-Related Disorders in Aged Apolipoprotein E Deficient Mice.

Pioglitazone Improves Mitochondrial Function in the Remnant Kidney and Protects Against Renal Fibrosis in 5/6 Nephrectomized Rats.

Pioglitazone, a Peroxisome Proliferator-Activated Receptor Γ Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model

Pioglitazone Attenuates Advanced Glycation End Products-Induced Apoptosis and Calcification by Modulating Autophagy in Tendon-Derived Stem Cells

PPARγ agonists delay age‐associated metabolic disease and extend longevity

Inhibition Of Reactive Oxygen Species/Extracellular Signal-Regulated Kinases Pathway By Pioglitazone Attenuates Advanced Glycation End Products-Induced Proliferation Of Vascular Smooth Muscle Cells In Rats

Pioglitazone Hydrochloride Extends the Lifespan of Caenorhabditis elegans by Activating DAF-16/FOXO- and SKN-1/NRF2-Related Signaling Pathways

Emerging Protective Actions of PGC-1α in Diabetic Nephropathy

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in Ob/ob Mice.

Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus

We-P11:120 Role of Peroxisome Proliferators Activated Receptor-Gama in Mediating Proliferation of Rat Vascular Smooth Muscle Cells Induced by Advanced Glycation End Products

Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway

Pioglitazone alleviates the mitochondrial apoptotic pathway and mito-oxidative damage in the d-galactose-induced mouse model

Pioglitazone Inhibits Advanced Glycation End Product-Induced Matrix Metalloproteinases and Apoptosis by Suppressing the Activation of MAPK and NF-κB.

Abstract 4887: The Thiazolidinedione Pioglitazone up-regulates Vascular Telomere Regulating Proteins and Prevents Cellular Senescence in Mice

Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.

Pioglitazone Protects PC12 Cells Against Oxidative Stress Injury: an in Vitro Study of Its Antiapoptotic Effects Via the PPARγ Pathway.

Pioglitazone Protects Tubular Cells Against Hypoxia/reoxygenation Injury Through Enhancing Autophagy Via AMPK-mTOR Signaling Pathway